MRK Merck KGaA
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Yesterday | ||
Older | ||
![]() Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. The German group is paying $73 a share in cash, valuing the business at about $11.3 billion including debt. They also voted down the executive compensation proposal attached to the deal, which is an unusual pairing. […] | ||
![]() Merck KGaA (XTRA:MRK) Clears Key Acquisition Hurdle After Shareholder Approval Merck KGaA (XTRA:MRK) has received shareholder approval from Bio-Techne investors for its planned acquisition of the US life sciences group. The vote clears a major corporate hurdle in the transaction process, with completion still subject to remaining regulatory reviews. The planned merger is expected to broaden the combined product set and customer reach across multiple stages of the life sciences workflow. The Bio-Techne shareholder approval is important, but it should not be the only... | ||

